NCT01657981View on ClinicalTrials.gov

A Study to Find Out How YM150 is Absorbed Into and Eliminated From the Body in Healthy Male Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

February 28, 2007

Primary Completion Date

March 31, 2007

Study Completion Date

March 31, 2007

Conditions
PharmacokineticsHealthy Male Subjects
Interventions
DRUG

YM150

14C-labeled YM150, oral solution

Trial Locations (1)

9471 GP

PRA International EDS NL, Zuidlaren

All Listed Sponsors
lead

Astellas Pharma Europe B.V.

INDUSTRY

NCT01657981 - A Study to Find Out How YM150 is Absorbed Into and Eliminated From the Body in Healthy Male Subjects | Biotech Hunter | Biotech Hunter